We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Extends Celebrex Patent, Sues Generic Makers
After receiving an 18-month patent extension for celecoxib, the active ingredient in Pfizer’s highly successful osteoarthritis drug Celebrex, the company announced it is suing five generic-drug makers for patent infringement.